文献速递心脑血管急症重症综合管理与镇静镇痛

左主干冠状动脉病变PCI与CABG五年结局比较

Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.
PubMed 文献 · N Engl J Med · 2019-09-28
一句话结论左主干低或中等解剖复杂度患者,PCI与CABG五年死亡、卒中或心肌梗死复合终点无显著差异,但PCI全因死亡更高、血运重建更频繁。

EXCEL试验随机分配1905例左主干低或中等解剖复杂度患者接受PCI(氟聚合物涂层钴铬依维莫司洗脱支架,948例)或CABG(957例),主要终点为死亡、卒中或心肌梗死复合终点。5年时PCI组22.0% vs CABG组19.2%发生主要终点事件(差值2.8个百分点,95%CI -0.9至6.5,P=0.13),无显著差异。PCI组全因死亡高于CABG组(13.0% vs 9.9%,差值3.1个百分点,95%CI 0.2至6.1),PCI组缺血驱动血运重建更频繁(16.9% vs 10.0%,差值6.9个百分点,95%CI 3.7至10.0)。该研究为左主干病变血运重建策略选择提供了长期随机对照证据。

要点

  • 左主干低或中等解剖复杂度患者,5年死亡、卒中或心肌梗死复合终点PCI组22.0% vs CABG组19.2%,差值2.8个百分点(95%CI -0.9至6.5,P=0.13),无显著差异。
  • PCI组全因死亡高于CABG组(13.0% vs 9.9%,差值3.1个百分点,95%CI 0.2至6.1)。
  • PCI组缺血驱动血运重建更频繁(16.9% vs 10.0%,差值6.9个百分点,95%CI 3.7至10.0)。
  • 心血管死亡(5.0% vs 4.5%)和心肌梗死(10.6% vs 9.1%)两组无显著差异。
  • 所有脑血管事件PCI组少于CABG组(3.3% vs 5.2%,差值-1.9个百分点,95%CI -3.8至0),但卒中单独比较无显著差异(2.9% vs 3.7%)。

适用人群与场景

  • 接受随机分组的左主干冠状动脉病变患者,解剖复杂度为低或中等(根据参与中心评估)。

处置流程与药物剂量

  • PCI组使用氟聚合物涂层钴铬依维莫司洗脱支架行经皮冠状动脉介入治疗。
  • CABG组行冠状动脉旁路移植术。

研究设计与关键结果

  • EXCEL试验随机分配1905例左主干冠状动脉病变患者至PCI组(948例)或CABG组(957例),主要终点为死亡、卒中或心肌梗死复合终点。
  • 5年时主要终点事件PCI组22.0% vs CABG组19.2%,差值2.8个百分点(95%CI -0.9至6.5,P=0.13),无显著差异。
  • 全因死亡PCI组13.0% vs CABG组9.9%,差值3.1个百分点(95%CI 0.2至6.1)。
  • 明确心血管死亡PCI组5.0% vs CABG组4.5%,差值0.5个百分点(95%CI -1.4至2.5),无显著差异。
  • 心肌梗死PCI组10.6% vs CABG组9.1%,差值1.4个百分点(95%CI -1.3至4.2),无显著差异。
  • 所有脑血管事件PCI组3.3% vs CABG组5.2%,差值-1.9个百分点(95%CI -3.8至0)。
  • 卒中PCI组2.9% vs CABG组3.7%,差值-0.8个百分点(95%CI -2.4至0.9),无显著差异。
  • 缺血驱动血运重建PCI组16.9% vs CABG组10.0%,差值6.9个百分点(95%CI 3.7至10.0)。

证据类型、等级与局限

  • 证据类型:随机对照试验(EXCEL,ClinicalTrials.gov NCT01205776)。
  • 由Abbott Vascular资助。

对床旁实践的改变

  • 对于左主干低或中等解剖复杂度患者,PCI与CABG五年死亡、卒中或心肌梗死复合终点无显著差异,但PCI全因死亡更高且缺血驱动血运重建更频繁。
  • 原文结论未据此给出推荐。

指南或共识出处

  • EXCEL试验(ClinicalTrials.gov NCT01205776),发表于N Engl J Med。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Long-term outcomes after percutaneous coronary intervention (PCI) with contemporary drug-eluting stents, as compared with coronary-artery bypass grafting (CABG), in patients with left main coronary artery disease are not clearly established.

METHODS: We randomly assigned 1905 patients with left main coronary artery disease of low or intermediate anatomical complexity (according to assessment at the participating centers) to undergo either PCI with fluoropolymer-based cobalt-chromium everolimus-eluting stents (PCI group, 948 patients) or CABG (CABG group, 957 patients). The primary outcome was a composite of death, stroke, or myocardial infarction.

RESULTS: At 5 years, a primary outcome event had occurred in 22.0% of the patients in the PCI group and in 19.2% of the patients in the CABG group (difference, 2.8 percentage points; 95% confidence interval [CI], -0.9 to 6.5; P = 0.13). Death from any cause occurred more frequently in the PCI group than in the CABG group (in 13.0% vs. 9.9%; difference, 3.1 percentage points; 95% CI, 0.2 to 6.1). In the PCI and CABG groups, the incidences of definite cardiovascular death (5.0% and 4.5%, respectively; difference, 0.5 percentage points; 95% CI, -1.4 to 2.5) and myocardial infarction (10.6% and 9.1%; difference, 1.4 percentage points; 95% CI, -1.3 to 4.2) were not significantly different. All cerebrovascular events were less frequent after PCI than after CABG (3.3% vs. 5.2%; difference, -1.9 percentage points; 95% CI, -3.8 to 0), although the incidence of stroke was not significantly different between the two groups (2.9% and 3.7%; difference, -0.8 percentage points; 95% CI, -2.4 to 0.9). Ischemia-driven revascularization was more frequent after PCI than after CABG (16.9% vs. 10.0%; difference, 6.9 percentage points; 95% CI, 3.7 to 10.0).

CONCLUSIONS: In patients with left main coronary artery disease of low or intermediate anatomical complexity, there was no significant difference between PCI and CABG with respect to the rate of the composite outcome of death, stroke, or myocardial infarction at 5 years. (Funded by Abbott Vascular; EXCEL ClinicalTrials.gov number, NCT01205776.).

来源:N Engl J Med,查看原文。版权归原作者所有。

参考来源

  1. Stone GW, Kappetein AP, Sabik JF, et al. Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease. N Engl J Med. 2019. PMID: 31562798. doi:10.1056/NEJMoa1909406

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。